SCHEMBL16974883

SCHEMBL16974883

Clc1ccc2c(c1)NC(NCCc1ccncc1)=NS2

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.39
GSK3B P49841 3/20 0.38
NOX1 Q9Y5S8 2/20 0.37
BCHE P06276 1/20 0.37
ACHE P22303 1/20 0.37
TAAR1 Q96RJ0 1/20 0.36
CCNC P24863 1/20 0.34
CDK8 P49336 1/20 0.34
HTT P42858 2/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
KCNH3 Q9ULD8 1/20 0.33
GPR84 Q9NQS5 1/20 0.33
SNCA P37840 1/20 0.32
GSK3A P49840 2/20 0.32
ROCK2 O75116 2/20 0.32
PGK1 P00558 1/20 0.32
DPP4 P27487 1/20 0.32
DPP8 Q6V1X1 1/20 0.32
DPP9 Q86TI2 1/20 0.32
GRK2 P25098 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16974903 0.90 GSK3B (0.40) KDM4EGSK3BNOX1BCHEACHE
SCHEMBL16974887 0.86 GSK3B (0.36) KDM4EGSK3BTAAR1HTTSMN1; SMN2
SCHEMBL16974854 0.86 HDAC8 (0.41) KDM4EGSK3BNOX1BCHEACHE
SCHEMBL16974842 0.85 CCNT1 (0.34) KDM4EGSK3BBCHEACHEHTT
SCHEMBL16974918 0.81 ALDH1A1 (0.34) KDM4EGSK3BHTTSMN1; SMN2KCNH3
SCHEMBL16974865 0.80 PKM (0.47) KDM4ENOX1BCHEACHETAAR1
SCHEMBL8583938 0.79 CCNC (0.43) KDM4ENOX1BCHEACHETAAR1
SCHEMBL8585833 0.79 CYP1A2 (0.39) KDM4ENOX1BCHEACHEHTT
SCHEMBL16974874 0.78 NOX1 (0.37) GSK3BNOX1TAAR1HTTSMN1; SMN2
SCHEMBL16974838 0.78 ROCK2 (0.40) KDM4EGSK3BTAAR1HTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3099304-A1 NOVEL THERAPEUTICS FOR THE TREATMENT OF GLAUCOMA Mayo Foundation for Medical Education and Research (US) 2016-12-07 EP disclosed
WO-2015117024-A1 NOVEL THERAPEUTICS FOR THE TREATMENT OF GLAUCOMA MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) 2015-08-06 WO disclosed